Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E GROSSBARD

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|August 16, 1979
Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemiaH E Broxmeyer, E Grossbard, N Jacobsen, et al.
Cell and Tissue Kinetics|March 1, 1979
Colony-forming units in diffusion chambers (CFU-d) and colony-forming units in agar culture (CFU-c) obtained from normal human bone marrow: a possible parent-progeny relationshipN Jacobsen, H E Broxmeyer, E Grossbard, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 27, 2010
Contribution of gut bacteria to the metabolism of the spleen tyrosine kinase (Syk) inhibitor R406 in cynomolgus monkeyD J Sweeny, W Li, E Grossbard, et al.
Cancer|April 15, 1980
Bone marrow transplantation for the therapy of refractory adult T cell acute lymphoblastic leukemiaT J Garrett, E Grossbard, S Hopfan, et al.
Circulation|June 1, 1987
A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectorisH K Gold, J A Johns, R C Leinbach, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|September 29, 2023
Occult myocardial injury is prevalent amongst elderly patients in the hospital-at-home setting. A retrospective analysis of 213 patientsY Marziano, E Abutbul, A Sharabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humansM J Hawkins, E C Borden, J A Merritt, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1973
Decreased globin messenger RNA in thalassemia detected by molecular hybridizationD L Kacian, R Gambino, L W Dow, et al.
Journal of the American College of Cardiology|January 1, 1985
Thrombolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusionE J Topol, A A Ciuffo, T A Pearson, et al.
Circulation|October 1, 1984
Coronary thrombolysis with recombinant human tissue-type plasminogen activatorH K Gold, J T Fallon, T Yasuda, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|August 16, 1979
Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemiaH E Broxmeyer, E Grossbard, N Jacobsen, et al.
Cell and Tissue Kinetics|March 1, 1979
Colony-forming units in diffusion chambers (CFU-d) and colony-forming units in agar culture (CFU-c) obtained from normal human bone marrow: a possible parent-progeny relationshipN Jacobsen, H E Broxmeyer, E Grossbard, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 27, 2010
Contribution of gut bacteria to the metabolism of the spleen tyrosine kinase (Syk) inhibitor R406 in cynomolgus monkeyD J Sweeny, W Li, E Grossbard, et al.
Cancer|April 15, 1980
Bone marrow transplantation for the therapy of refractory adult T cell acute lymphoblastic leukemiaT J Garrett, E Grossbard, S Hopfan, et al.
Circulation|June 1, 1987
A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectorisH K Gold, J A Johns, R C Leinbach, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|September 29, 2023
Occult myocardial injury is prevalent amongst elderly patients in the hospital-at-home setting. A retrospective analysis of 213 patientsY Marziano, E Abutbul, A Sharabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humansM J Hawkins, E C Borden, J A Merritt, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1973
Decreased globin messenger RNA in thalassemia detected by molecular hybridizationD L Kacian, R Gambino, L W Dow, et al.
Journal of the American College of Cardiology|January 1, 1985
Thrombolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusionE J Topol, A A Ciuffo, T A Pearson, et al.
Circulation|October 1, 1984
Coronary thrombolysis with recombinant human tissue-type plasminogen activatorH K Gold, J T Fallon, T Yasuda, et al.
Pageof 1